EP1697744 - SCREENING METHOD [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 11.12.2009 Database last updated on 27.07.2024 | Most recent event Tooltip | 11.12.2009 | Application deemed to be withdrawn | published on 13.01.2010 [2010/02] | Applicant(s) | For all designated states AstraZeneca AB 151 85 Södertälje / SE | [N/P] |
Former [2006/36] | For all designated states AstraZeneca AB S-151 85 Södertälje / SE | Inventor(s) | 01 /
BANTICK, John, Raymond 78 Melton Road, Burton on the Wolds Loughborough, Leicestershire LE12 5AG / GB | 02 /
COOK, Ian, David AstraZeneca R & D Alderley, Alderley Park Macclesfield, Cheshire SK10 4TG / GB | 03 /
DONALD, David, Keith AstraZeneca R & D Charnwood, Bakewell Road Loughborough, Leicestershire LE11 5RH / GB | 04 /
HUTCHINSON, Raymond AstraZeneca R & D Charnwood, Bakewell Road Loughborough, Leicestershire LE11 5RH / GB | 05 /
JACKSON, Andrew, Paul AstraZeneca R & D Charnwood, Bakewell Road Loughborough, Leicestershire LE11 5RH / GB | 06 /
JACKSON, Clive, Geoffrey AstraZeneca R & D Charnwood, Bakewell Road Loughborough, Leicestershire LE11 5RH / GB | 07 /
MURRAY, Clare, Margaret AstraZeneca R & D Charnwood, Bakewell Road Loughborough, Leicestershire LE11 5RH / GB | 08 /
SULLIVAN, Michael AstraZeneca R & D Charnwood, Bakewell Road Loughborough, Leicestershire LE11 5RH / GB | [2006/36] | Application number, filing date | 03778501.1 | 21.11.2003 | [2006/36] | WO2003GB05072 | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2005054852 | Date: | 16.06.2005 | Language: | EN | [2005/24] | Type: | A1 Application with search report | No.: | EP1697744 | Date: | 06.09.2006 | Language: | EN | The application published by WIPO in one of the EPO official languages on 16.06.2005 takes the place of the publication of the European patent application. | [2006/36] | Search report(s) | International search report - published on: | EP | 16.06.2005 | Classification | IPC: | G01N33/50 | [2006/36] | CPC: |
G01N33/5011 (EP);
G01N33/6872 (EP)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2006/36] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | Title | German: | SCREENINGVERFAHREN | [2006/36] | English: | SCREENING METHOD | [2006/36] | French: | METHODE DE CRIBLAGE | [2006/36] | Entry into regional phase | 21.06.2006 | National basic fee paid | 21.06.2006 | Designation fee(s) paid | 21.06.2006 | Examination fee paid | Examination procedure | 21.06.2006 | Examination requested [2006/36] | 12.03.2009 | Despatch of a communication from the examining division (Time limit: M04) | 23.07.2009 | Application deemed to be withdrawn, date of legal effect [2010/02] | 26.08.2009 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2010/02] | Fees paid | Renewal fee | 21.06.2006 | Renewal fee patent year 03 | 30.11.2006 | Renewal fee patent year 04 | 30.11.2007 | Renewal fee patent year 05 | 28.03.2008 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XA]WO0222678 (PE CORP NY) [X] 1,3,5,7-14 * p. 13, lines 8 - 16, p. 23, lines 19 - 23, p. 24, line 17 - p. 26, line 24, claims 14 - 17, 19, fig. 2 and 4 * [A] 2,4; | [XA]US2003166522 (YAN CHUNHUA ET AL) [X] 1,3,5,7-14 * p. 6, [0063] and [0064], p. 10 [0108] - p. 11 [0116], claims 14 - 17, 19, Seq. ID Nos 4 and 5 * [A] 2,4; | [A]US6342601 (COOPER MARTIN ET AL) [A] 15-24 * column 13, line 45 - line 53; examples 3,18 *; | [X] - ENERSON BRADLEY E ET AL, "Molecular features, regulation, and function of monocarboxylate transporters: Implications for drug delivery.", JOURNAL OF PHARMACEUTICAL SCIENCES, (200308), vol. 92, no. 8, ISSN 0022-3549, pages 1531 - 1544, XP002274983 [X] 14,15 * page 1534; table 1 * DOI: http://dx.doi.org/10.1002/jps.10389 | [X] - MANNING FOX J E ET AL, "Characterisation of human monocarboxylate transporter 4 substantiates its role in lactic acid efflux from skeletal muscle.", THE JOURNAL OF PHYSIOLOGY. ENGLAND 1 DEC 2000, (20001201), vol. 529 Pt 2, ISSN 0022-3751, pages 285 - 293, XP002274984 [X] 14,15 * item 6 of the abstract * DOI: http://dx.doi.org/10.1111/j.1469-7793.2000.00285.x | [A] - YOON H ET AL, "Cloning of the Human Monocarboxylate Transporter MCT3 Gene: Localization to Chromosome 22q12.3-q13.2", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, (19990915), vol. 60, no. 3, ISSN 0888-7543, pages 366 - 370, XP004444809 [A] 1-24 * the whole document * DOI: http://dx.doi.org/10.1006/geno.1999.5926 |